Claritev (CTEV) opened 2026 with Q1 revenue of US$244.7 million and a basic EPS loss of US$4.41, while trailing twelve month revenue sat at US$978.8 million against a TTM basic EPS loss of US$17.32 and TTM net loss of US$286.5 million. Over recent quarters, revenue has moved from US$231.3 million in Q1 2025 to US$244.7 million in Q1 2026, as quarterly basic EPS losses have stayed in a tight range around US$4 to US$5. This keeps the focus firmly on how quickly Claritev can tighten margins and stem ongoing losses.

See our full analysis for Claritev.

With the headline numbers set, the next step is to see how this earnings print lines up against the prevailing narratives around Claritev's growth potential, risk profile, and path toward healthier margins.

Losses Stay Heavy At TTM US$286.5 Million

• On a trailing 12 month basis, Claritev reported a net loss of US$286.5 million on US$978.8 million of revenue, with TTM basic EPS at a loss of US$17.32, compared with a single quarter Q1 2026 loss of US$73.56 million and basic EPS loss of US$4.41.
• Critics highlight that losses have widened at about 26% per year over the past five years and see forecasts for continued unprofitability as a key risk, while the current TTM loss of US$286.5 million and Q1 loss of US$73.56 million underline that the path to positive margins has not yet shown up in the reported numbers.
  • This supports the bearish concern that higher regulatory, compliance, and operating costs could continue to pressure earnings even as quarterly revenue sits near US$240 million to US$250 million.
  • At the same time, the fact that TTM losses are smaller than the very large loss reported five years ago means bears are watching closely to see whether cost initiatives and AI investments actually translate into a sustained improvement in EPS from the current TTM loss of US$17.32 per share.

Claritev's multi year loss profile and the size of the current TTM loss are exactly what skeptics point to when they question how quickly the story can shift toward earnings strength, so it is worth checking how that caution stacks up against the more detailed bear case view 🐻 Claritev Bear Case.

Revenue Growth Trails Market At 3.9%

• Over the last 12 months, Claritev's revenue grew at 3.9% per year, compared with the broader US market growth benchmark of 11.4% per year, while quarterly revenue has stayed in a tight band around US$241.6 million to US$246.6 million over the past four quarters.
• Supporters of the consensus narrative argue that accelerated AI adoption and new international markets can support sustainable revenue growth, yet the reported 3.9% annual growth rate and the relatively flat quarterly revenue run rate mean the current top line sits well below the 11.4% US market benchmark.
  • This contrast puts pressure on the idea that international expansion and multi year client renewals already translate into stronger growth, because the latest TTM revenue of US$978.8 million is not far from the US$930.6 million level reported six quarters ago.
  • For investors weighing the consensus view, the key question is whether the modest 3.9% growth and stable quarterly revenue levels are an early base for future acceleration or simply evidence that Claritev is growing slower than the broader market for now.

"Cheap" P/S Multiple Versus High Risk Profile

• Claritev trades on a P/S of about 0.4x against industry and peer averages near 2.1x to 2.2x, and the current share price of US$24.21 sits well below the cited DCF fair value of US$107.50 and the analyst consensus price target of US$39.80.
• Supporters of the bullish narrative point to this discount and argue that AI driven efficiency and recurring revenue could justify higher valuations, yet the low P/S multiple, negative shareholders' equity, and less than one year of cash runway show that the market is also weighing balance sheet strain and ongoing losses.
  • The gap between the US$24.21 share price and the US$39.80 analyst target, alongside TTM revenue of US$978.8 million, heavily supports the bullish case that the stock may be priced as if growth and margin gains will fall short of expectations.
  • On the other hand, the combination of a 0.4x P/S multiple, a TTM loss of US$286.5 million, and less than one year of cash runway gives bears concrete reasons to argue that the discount reflects meaningful financial risk rather than an obvious bargain.

If you want to see how bullish investors reconcile that low P/S ratio, the loss profile, and the big gap to estimated DCF fair value, it is worth reading the full bull case on Claritev 🐂 Claritev Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Claritev on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With mixed signals, clear risks, and some potential rewards in view, it may be helpful to review the detailed breakdown and consider those 2 key rewards and 4 important warning signs

See What Else Is Out There

Claritev is operating with significant trailing twelve‑month (TTM) losses, modest 3.9% revenue growth compared with an 11.4% market benchmark, and balance sheet pressure that includes less than one year of cash runway.

If those earnings and risk trade offs feel uncomfortable, you may want to compare them with companies in the 72 resilient stocks with low risk scores that prioritize resilience and financial strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.